全球优质白内障手术 (PCS) 市场（2023 年）：前 13 个国家分析（2023-2029 年）

本报告审视了全球优质白内障手术 (PCS) 市场，提供了市场概况、全球白内障手术和产品收入分析、主要趋势、未来成功关键推动因素的讨论，并提供了前 13 个国家的市场趋势。

目录

• 老花眼矫正人工水晶体
• 复曲面人工晶状体
• 中间优化人工水晶体
• 术后可调式人工水晶体
• FLAC雷射
• FLACS弓形切口法
• 手动角膜缘减压切口
• 准分子人工水晶体增强术
• 前 13 个 PCS 市场（美国、中国、日本、法国、德国、巴西、加拿大、印度、西班牙、韩国、澳洲、英国、义大利）的概述和详细概况
  • 每个国家的执行摘要
  • 各国白内障手术费用分析
  • 按国家/地区划分的 PCS 手术和製造商收入预测
  • 按国家/地区划分的医疗保健提供者 PCS 手术收入和预测
  • 各主要国家中纯白内障外科医生、白内障/屈光外科医生和仅屈光外科医生进行的 PCS 手术的百分比
  • 按国家和全球 PCS 市场划分的製造商收入市场占有率
  • 按国家列出最重要的 PCS 眼科医院和诊所
  • 接下来六个最重要的 PCS 国家的市场规模排名

What's New:

The new "2024 Premium Cataract Surgery Market Report" now features a five-year history of PC-IOLs, toric IOLs, and FLACS for each of the top 13 premium cataract surgery country markets in the world. For each of these countries, the report also analyzes the recent economy and projects its impact on the elderly populations that account for most premium procedures.

INFOGRAPHICS

The report also explores the long list of recently launched new products that are destined to impact the premium cataract market-including the Carl Zeiss Micor 700 cataract handpiece, which has the potential to drive adoption of office-based cataract surgery; the Rayner Galaxy spiral trifocal IOL and many other new PC-IOLs; and the Lensar Ally, which is expected to drive growth in FLACS procedures.

The new report also examines and explains the dramatic drop in premium procedures in South Korea and outlines the potential recovery of that market over the next five years.

The "2024 Premium Cataract Surgery Market Report" is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We've selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market.

Contents:

The report offers an in-depth examination of the 2024 premium cataract surgery (PCS) market. It includes analysis of the global PCS procedure and product revenue, identification of important trends, and discussion of key factors for future success. The following information is also included:

• Presbyopia-correcting, toric, intermediate-optimized, and post-op adjustable IOLs, FLACS lasers, FLACS arcuate incisions, manual limbal relaxing incisions, and excimer IOL enhancements.
• Snapshots and in-depth profiles of the top 13 PCS markets: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
• Individual country executive summary.
• Analysis of the cost of public and private cataract surgery options by country.
• Forecasts for PCS procedures and manufacturer revenue by country.
• Forecasts for provider revenue resulting from PCS procedures by country.
• Percentage of PCS procedures performed in each key country by cataract-only, cataract/refractive, and refractive-only surgeons.
• Manufacturer revenue market shares of the PCS market in each country and globally.
• Listing of the most important PCS eye hospitals and clinics by country.
• A list of the next six most important PCS countries ranked by market size.